High-sensitivity modified Glasgow prognostic score (HS-mGPS) is a prognostic biomarker for small duct-type intrahepatic cholangiocarcinoma—a retrospective cohort study
HS-mGPS provides a more accurate prognostic indication for SD-type, but its effectiveness for LD-type requires further investigation with larger sample sizes. Therefore, for preoperatively biopsy-diagnosed SD-type ICC, the HS-mGPS has a certain level of prognostic predictive potential.
Authors
- Zixin Liang (ORCID: https://orcid.org/0000-0002-6621-8841)
- Xiaoping Qian (ORCID: https://orcid.org/0000-0002-5025-5269)
- Jun Chen (ORCID: https://orcid.org/0000-0001-5914-9158)
- Hongyan Wu (ORCID: https://orcid.org/0009-0002-8754-8126)
- Youxiang Ding
- Shuo Zhang (ORCID: https://orcid.org/0000-0002-1572-6192)
- Xintao He
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/tcr-24-917
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00